1. Home
  2. NRXP vs VTSI Comparison

NRXP vs VTSI Comparison

Compare NRXP & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • VTSI
  • Stock Information
  • Founded
  • NRXP 2015
  • VTSI 1993
  • Country
  • NRXP United States
  • VTSI United States
  • Employees
  • NRXP N/A
  • VTSI N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • VTSI Miscellaneous manufacturing industries
  • Sector
  • NRXP Health Care
  • VTSI Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • VTSI Nasdaq
  • Market Cap
  • NRXP 58.5M
  • VTSI 60.6M
  • IPO Year
  • NRXP N/A
  • VTSI N/A
  • Fundamental
  • Price
  • NRXP $2.89
  • VTSI $5.38
  • Analyst Decision
  • NRXP Strong Buy
  • VTSI Strong Buy
  • Analyst Count
  • NRXP 4
  • VTSI 1
  • Target Price
  • NRXP $28.50
  • VTSI $7.00
  • AVG Volume (30 Days)
  • NRXP 283.3K
  • VTSI 98.7K
  • Earning Date
  • NRXP 08-19-2025
  • VTSI 08-11-2025
  • Dividend Yield
  • NRXP N/A
  • VTSI N/A
  • EPS Growth
  • NRXP N/A
  • VTSI N/A
  • EPS
  • NRXP N/A
  • VTSI 0.10
  • Revenue
  • NRXP N/A
  • VTSI $27,068,543.00
  • Revenue This Year
  • NRXP N/A
  • VTSI $9.92
  • Revenue Next Year
  • NRXP $230.95
  • VTSI $16.54
  • P/E Ratio
  • NRXP N/A
  • VTSI $53.84
  • Revenue Growth
  • NRXP N/A
  • VTSI N/A
  • 52 Week Low
  • NRXP $1.10
  • VTSI $3.57
  • 52 Week High
  • NRXP $6.01
  • VTSI $8.53
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 54.48
  • VTSI 35.77
  • Support Level
  • NRXP $2.30
  • VTSI $5.11
  • Resistance Level
  • NRXP $2.68
  • VTSI $7.27
  • Average True Range (ATR)
  • NRXP 0.19
  • VTSI 0.43
  • MACD
  • NRXP 0.02
  • VTSI -0.20
  • Stochastic Oscillator
  • NRXP 89.39
  • VTSI 11.44

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: